期刊文献+

乙型肝炎病毒感染患者发病中CD_8^+T细胞的临床作用机制研究 被引量:3

Clinical mechanism of CD_8^+ T cells in patients with hepatitis B virus infection
原文传递
导出
摘要 目的研究CD8+T细胞在乙型肝炎病毒(HBV)感染患者发病中的临床作用机制,为临床控制HBV感染提供参考依据。方法选取2012年5月-2015年5月于医院接受治疗126例乙型肝炎患者为试验组,同期选择32名健康体检者为对照组,比较两组受试者生化指标等,数据采用SPSS 18.0软件进行统计分析。结果试验组患者血清丙氨酸氨基转移酶、天冬氨酸氨基转化酶、γ-谷氨酸转移肽酶、总胆红素、直接胆红素以及球蛋白水平明显高于对照组,差异有统计学意义(P<0.05)。结论 CD8+T细胞是控制HBV感染的关键,采取有效措施监测T细胞各种亚群及病毒载量,并开展有效的抗病毒治疗,将有利于提高患者HBV感染的治疗效果。 OBJECTIVE To study the CD8+T cells in clinical mechanisms of the pathogenesis of hepatitis B virus(HBV)infection,so as to provide reference for clinical control of HBV infection.METHODS A total of 126 cases of hepatitis B patients with HBV treated in hospital from May 2012 to May 2015 were selected as the experimental group,another 32 cases of the same period of alternative healthy people as control group.These two groups were under comparison of biochemical indexes.SPSS 18.0was used for data analysis.RESULTS In the experimental group,the serum levels of alanine aminotransferase,aspartate amino invertase,γ-glutamate transfer peptide enzyme,total bilirubin,direct bilirubin and globulin were significantly higher than those in the control group(P〈0.05).CONCLUSIONCD8+T cells is the key to control HBV.Effective measures should be taken to monitor a variety of T cell subsets and viral load.The treatment for anti-viral is necessary which could help to improve the treatment of patients with HBV infection.
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2016年第16期3625-3627,共3页 Chinese Journal of Nosocomiology
基金 湖北省自然科学基金资助项目(2013CFB254)
关键词 CD8+T细胞 HBV感染 临床作用机制 CD8+ T cells Hepatitis B virus infection Clinical effect mechanism
  • 相关文献

参考文献6

二级参考文献23

  • 1中华医学会肝病学分会,中华医学会感染病学分会.慢性乙型肝炎防治指南[J].传染病信息,2005,18(z1):1-12. 被引量:466
  • 2Rehermann B, Nascimbeni M. Immunology of hepati- tis B virus and hepatitis C virus infection [ J ]. Nat Rev Immunol, 2005, 5(3):215-229. 被引量:1
  • 3Bertoletti A, FeiTari C. Kinetics of the immune res- ponse during HBV and HCV infection[ J]. Hepato- logy, 2003, 38(1) : 4-13. 被引量:1
  • 4Frebel H, Richter K, Oxenius A. How chronic viral infections impact on antigen-specific T-cell responses [J]. Eur J Immunol, 2010, 40(3) : 654-663. 被引量:1
  • 5Kim PS, Ahmed R. Features of responding T cells in cancer and chronic infection [ J ]. Curr Opin Immunol, 2010, 22(2): 223-230. 被引量:1
  • 6Penna A, Chisari FV, Bertoletti A, et al. Cytotoxic T lymphocytes recognize an HLA-A2-restricted epitope within the hepatitis B virus nucleocapsid antigen[ J]. J Exp Med, 1991, 174(6) : 1565-1570. 被引量:1
  • 7Sobao Y, Sugi K, Tomiyama H, et al. Identification of hepatitis B virus-specific CTL epitopes presented by HLA-A * 2402, the most common HLA class I allele in East Asia [ J 1. J Hepatol, 2001, 34 ( 6 ) : 922 -929. 被引量:1
  • 8Williams MA, Bevan MJ. Effector and memory CTL differentiation [ J ]. Annu Rev Immunol, 2007,25 : 171-192. 被引量:1
  • 9Fisicaro P, Valdatta C, Massari M, ct al. Antiviral intrahepatic T-cell responses can be restored by bloc- king programmed death-1 pathway in chronic hepatitis B[J]. Gastroenterology, 2010, 138(2):682-693. 被引量:1
  • 10Cai G, Nie X, Li L,et al. B and T lymphocyte atte- nuator is highly expressed on intrahepatic T cells during chronic HBV infection and regulates their function[J]. J Gastroenterol, 2013. [Epub ahead of print]. 被引量:1

共引文献10

同被引文献72

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部